Release Date: 30/10/09 17:43 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 424.85KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%